A dosimetry study for chest, skull and lumbar spine examinations in adults has been carried out at two hospitals. The aim of the study was the assessment of adult patient’s dose for chest PA, chest LAT, skull AP and lumbar spine AP examinations. The Entrance Surface Dose (ESD) and the Effective Dose (ED) for each examination were obtained using DoseCal software. For each examination, different results were obtained at the two hospitals. At hospital A (IFF Hospital), the total number of patients studied was 140. The mean ESD values obtained for chest PA, chest LAT, skull AP and lumbar spine AP were 0.20 mGy, 0.47 mGy, 1.25 mGy, and 1.61 mGy, respectively. At hospital B (HGB Hospital), the total number of patients studied was 369 for similar examinations and projections. The ESD values were 0.10 mGy, 0.28 mGy, 0.66 mGy and 2.47 mGy, respectively. The mean ED values at hospital A and B were 0.02 mSv and 0.01 mSv for chest PA, 0.04 mSv and 0.03 mSv for chest LAT, 0.1 mSv and 0.06 mSv for skull AP, and 0.15 mSv and 0.26 mSv for lumbar spine AP, respectively. The results were compared with the European Community Reference Levels. Although the doses were low, there was still a need for personnel training and national guidance on good practice for optimization of patients’ doses.
The increasing knowledge of the hazards of ionising radiation has necessitated the need for radiation dose assessment of patients during diagnostic X-ray examinations especially the Effective Dose equivalent which is a risk related factor for describing the detriment of the exposure to radiation as introduced in ICRP 26 [
A quality assurance (QA) programme in diagnostic radiology should include the patient dosimetry as the most relevant item to be assessed, together with image quality. Council Directive 97/43/Euratom [
This study aims at establishing Entrance Skin Dose (ESD) and Effective Dose (ED) for three examinations, chest PA and LAT, skull AP and lumbar spine AP in two hospitals, and the main goal of this study is to improve the diagnostic information and to reduce the patient’s dose to a minimum.
Dose measurements were performed in two different hospitals namely A(IFF) and B(HGB) hospital, with 140 patients and 369 patients respectively. Data were collected on patient doses for a period of 5 months. The dose values were obtained with the use of DoseCal software that provides ESD and ED. This software has been used successfully to perform patient doses in some UK hospitals [
where:
S is the standard output factor in
minimal scatter conditions at 1m from the tube focus at nominal 80 kV;
mAs is the product of tube current and exposure time;
kV is the tube potential;
FSD is the Focus-to-Skin Distance; and
B is the backscatter factor.
The descriptive statistics of ESD (mGy), mean, standard deviation, CV%, minimum, first and third quartile, maximum, and the mean Effective Dose, ED (mSv) are given in
Figures 1-4 show the distributions of ESD (mGy) with first and third quartiles, mean, NRPB and EC reference dose levels for chest LAT and Lumbar Spine AP in the two hospitals.
The two hospitals give different ESD values for all the examinations. Despite the fact that the exposure factors used in hospital B are higher, than hospital A, Hospital A still gives higher ESD values for all the examina- tions except lumbar spine AP. This may be as a result of the difference in filtration and technical factors as shown in
The results obtained in
The mean ESD values of 1.25 and 0.66 mGy for skull AP and 1.61 and 2.47 mGy for lumbar spine AP for
Examinations and Projection | Hospita A (lFF ) | Hospital B (HGB) |
---|---|---|
Chest PA | ESD (mGy) | |
Mean | 0.20 | 0.10 |
SD | 0.07 | 0.03 |
CV (%) | 5.0 | 2.0 |
Minimum | 0.07 | 0.03 |
First Quartile | 0.13 | 0.08 |
Third Quartile | 0.24 | 0.12 |
Maximum | 0.47 | 0.29 |
Median | 0.18 | 0.09 |
Sample Size | 61 | 215 |
Effective Dose (mSv) | 0.02 | 0.01 |
Chest LAT | ESD (mGy ) | |
Mean | 0.47 | 0.28 |
SD | 0.25 | 0.15 |
CV (%) | 7.1 | 5.7 |
Minimum | 0.07 | 0.02 |
First Quartile | 0.21 | 0.19 |
Third Quartile | 0.66 | 0.30 |
Maximum | 1.33 | 0.91 |
Median | 0.45 | 0.25 |
Sample Size | 56 | 88 |
Effective Dose (mSv) | 0.04 | 0.03 |
Skull AP | ESD (mGy) | |
Mean | 1.25 | 0.66 |
SD | 0.41 | 0.31 |
CV(%) | 8.7 | 16.6 |
Minimum | 0.23 | 0.33 |
First Quartile | 0.83 | 0.40 |
Third Quartile | 1.47 | 0.56 |
Maximum | 2.47 | 1.77 |
Median | 0.40 | 0.52 |
Sample Size | 14 | 8 |
Effective Dose (mSv) | 0.10 | 0.06 |
Lumbar Spine AP | ESD (mGy) | |
Mean | 1.61 | 2.47 |
SD | 0.74 | 1.24 |
CV (%) | 14.5 | 2.2 |
Minimum | 0.14 | 0.29 |
First Quartile | 0.82 | 1.42 |
Third Quartile | 2.08 | 3.36 |
Maximum | 3.06 | 6.29 |
Median | 0.71 | 2.21 |
Sample Size | 10 | 57 |
Effective Dose (mSv) | 0.15 | 0.26 |
Examination | A | B | *RDLs |
---|---|---|---|
Chest PA | 0.20 | 0.10 | 0.3 |
Chest LAT | 0.47 | 0.28 | 1.5 |
Skull AP | 1.25 | 0.66 | 5.0 |
Lumbar Spine AP | 1.61 | 2.47 | 10.0 |
*RDLs: NRPB 1999 [
Examination | Tube Potential (kV) | (mAs) | FSD (cm) | Filtration (mm Al) |
---|---|---|---|---|
Chest PA | 55 - 90 | 4 - 16 | 110 - 180 | 2.00 - 2.50 |
Chest LAT | 62 - 100 | 4 - 32 | 100 - 180 | |
Skull AP | 50 - 80 | 16 - 32 | 100 - 150 | |
Lumbar Spine AP | 54 - 75 | 16 - 50 | 100 - 150 |
Examination | Tube Potential (kV) | (mAs) | FSD (cm) | Filtration (mm Al) |
---|---|---|---|---|
Chest PA | 48 - 100 | 5 - 20 | 115 - 170 | 2.00 - 3.00 |
Chest LAT | 70 - 117 | 6.4 - 42 | 68 - 165 | |
Skull AP | 52 - 70 | 10 - 50 | 76 - 150 | |
Lumbar Spine AP | 65 - 96 | 20 - 160 | 75 - 112 |
both hospitals respectively show a clear difference between the two hospitals. This difference may be due to the different technical factors used. For lumbar spine AP, the mAs used in hospital B was 3 times higher than in
hospital A, and the FSD was lower.
Similar examinations carried out in Sudan at four hospitals eight X-ray units and a sample of 346 radiographs. Hospital mean ESDs estimated range from 0.17 to 0.27 mGy for chest AP, 1.04 - 2.26 mGy for Skull AP/PA, 1.46 - 3.33 mGy for Lumbar Spine AP [
These values are also lower than those of the RDLs. However, they are higher than those obtained in this study at the two hospitals with 5 X-ray machines,
The Effective Doses obtained at the two hospitals, hospital A and B, were 0.02 and 0.01 mSv for chest PA, 0.04 and 0.03 mSv for chest LAT, 0.1 and 0.06 mSv for skull AP, 0.15 and 0.26 mSv for lumbar spine, respectively. The results obtained at the two hospitals were found to be lower than the EC reference dose levels.
For all the examinations studied in the two hospitals, the mean ESD values obtained are found to be within the
established international reference doses. For chest examinations, the results obtained are very close to the reference dose level. It is concluded that there is no potential health hazard to patients due to exposure during X- ray diagnostic examinations for chest, skull and lumbar spine at the two hospitals.
For skull AP and lumbar spine AP for both hospitals, the result obtained show a clear difference between the two hospitals. This difference may be due to the different technical factors used in
So (QA) Programme organized on a central basis can be a useful instrument to reach every hospital, with the aim of improving and optimizing the radiological practice.